KTRA - Kintara Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Kintara Therapeutics's activity chart (see below) currently has 5 price targets and 8 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 58.33% of the time, taking 292 days on average.

Most recent stock forecast was given by from MAXIM GROUP on 14-Jul-2023. First documented stock forecast 14-Aug-2017.

Best performing analysts who are covering KTRA - Kintara Therapeutics:

Jason Mccarthy Nathan Weinstein Michael King

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Jul-2023

$14

3 years 4 months 7 days ago
(14-Jul-2023)

2/2 (100%)

$-148.4 (-91.38%)

593

Buy Since 29-Sep-2021

$750000

$300

4 years 10 months 1 days ago
(20-Jan-2022)

1/2 (50%)

$749271.12 (102799.01%)

223

Buy Since 14-Sep-2020

$250

5 years 1 months 20 days ago
(01-Oct-2021)

1/1 (100%)

$-1202.5 (-82.79%)

356

Show more analysts

Please expand the browser size to see the chart

What is KTRA (Kintara Therapeutics) average time for price targets to be met?

On average it took 292 days for the stock forecasts to be reached, with an average price target met ratio of 58.33%.

Which analyst most recently updated their price target on KTRA (Kintara Therapeutics)?

Which analyst has the most public recommendations on KTRA (Kintara Therapeutics)?

has 0 price targets and 0 ratings on KTRA

Which analyst is the currently most bullish on KTRA (Kintara Therapeutics)?

Michael King with the highest potential upside of $749993.69

Which analyst is the currently most reserved on KTRA (Kintara Therapeutics)?

Jason Mccarthy with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?